1. ALLA AKTIER
  2. NYHETER
  3. CHORDATE MEDICAL

Chordate Medical

Nyheter Chordate Medical Nyheter alla bolag

Chordate Medical Holding’s Preference Share Admitted to Trading on Nasdaq First North Growth Market with First Trading Day on March 17th, 2025

MARKN.

Chordate Medical Holding has received approval for the listing of its preference share on Nasdaq First North Growth Market, with the first trading day set for Monday, March 17th, 2025.

In connection with Chordate Medical Holding’s recently completed rights issue, units consisting of common shares and preference shares were issued. Paid subscribed units (BTU) have now been converted into shares and preference shares. The number of issued preference shares amounts to 1,591,144 and will be traded under the ticker symbol CMH Pref with ISIN code SE0023848619.

The preference share is subject to a redemption clause and, under certain specified circumstances, entitles the holder to a dividend of up to SEK 12 per preference share, with priority over common shares. The full terms and conditions for the preference shares are outlined in the articles of association adopted at an extraordinary general meeting on January 28, 2025.

For more information, please contact:
Anders Weilandt, CEO
anders.weilandt@chordate.com
Cell: +46 733-874277

About Chordate
Chordate Medical Holding AB (publ) is a medical technology company that has developed, patented and CE-marked Ozilia® Migraine, a neuromodulation and drug-free treatment technology for chronic migraine and chronic rhinitis. The treatment has clinically proven efficacy according to a recent study, and is marketed in selected markets in the EU and the Middle East. Chordate Medical is listed on Nasdaq First North Growth Market Stockholm (ticker: CMH). Read more at www.chordate.com

The company's Certified Adviser on Nasdaq First North Growth Market Stockholm is Vator Securities AB.

N.B. The English text is an in-house translation of the original Swedish text. Should there be any disparities between the Swedish and the English text, the Swedish text shall prevail.

Attachments
Chordate Medical Holding’s Preference Share Admitted to Trading on Nasdaq First North Growth Market with First Trading Day on March 17th, 2025

Datum 2025-03-14, kl 16:20
Källa MFN
Bifogade filer
Chordate Medical Holding’s Preference Share Admitted to Trading on Nasdaq First North Growth Market with First Trading Day on March 17th, 2025
Affiliate
Skapa konto direkt med BankID hos Skilling så får du tillgång till tusentals finansmarknader inom valuta, aktier, krypto och mycket mer. Välj bland 1200+ CFD-instrument över 7 tillgångsklasser till konkurrenskraftiga priser. Skilling erbjuder också en kapitalförsäkring.
CFD är komplexa instrument och har en hög risk att förlora pengar snabbt på grund av hävstång. 77% av icke-professionella kunder förlorar pengar när de handlar med CFD med denna leverantör.